Cyclin D1 overexpression in invasive breast cancers: Correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 8-9, 1999, Pages 505-512

  Takano, Yasuo ^a,c   Takenaka, Haruyuki ^b   Kato, Yo ^c   Masuda, Mitsunobu ^d   Mikami, Tetsuo ^a   Saegusa, Makoto ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Toshiba Rinkan Hospital   (Japan)

^c CANCER INSTITUTE   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Breast cancer; Cyclin D1; Cyclin dependent kinase 4; Oestrogen receptor; Proliferation

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS RATE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MITOTIC INDEX; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 0032846412     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050309     Document Type: Article

References (34)

1. Adnane J, Gaudray P, Simon M-P, Simoney-Lafontaine J, Jeanteur P, Theillet C (1989) Proto-oncogene amplification and human breast tumor phenotype. Oncogene 4:138-1395
2. Alle KM, Henshall SM, Field AS, Sutherland RL (1998) Cyclin D1 proteins is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin Cancer Res 4:847-854
3. Baldin V, Lukas J, Marcrote MJ, Pagano M, Draetta G (1993) Cyclin D1 is nuclear protein required for cell cycle progression in G1. Genes Dev 7:812-821
4. Bartkova J, Lukas J, Strauss M, Bartek J (1995) Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 10:775-778
5. Beato M (1991) Transcriptional control by nuclear receptors. FASEB J 5:2044-2051
6. Beato M, Herrlich P, Schuetz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
7. Bloom HJG, Richardson JJ (1957) Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359-377
8. Diest PJ van, Michalides RJAM, Jannink I, Valk P van der, Peterse HL, Jong JS de, Meijer CJLM, Baak JPA (1997) Cyclin D1 in invasive breast cancer; correlations and prognostic value. Am J Pathol 150:705-711
9. Dubik D, Shiu RP (1988) Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J Biol Chem 263:12 705-12 708
10. Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N, Beger HG (1997) Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 57:1634-1637
11. Gillet C, Fantle V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812-1817
12. Gillet C, Smith P, Gregory W, Richards M, Millis R, Peters G (1996) Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69:92-99
13. Gramlich TL, Fritsch CR, Maurer D, Eberle M, Gansler TS (1994) Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma. Diagn Mol Pathol 3:255-259
14. Jares P, Rey M, Fernandez PL, Campo E, et al (1997) Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status. J Pathol 182:160-166
15. Keyomarsi K, Pardee AB (1993) Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90:1112-1116
16. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT (1993) Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 53:5535-5541
17. Kumar V, Chambon P (1988) The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55:145-156
18. Michalides R, Hageman P, Tinteren H, Houben L, Wientjens E, Klompmarker R, Peterse J (1996) A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73:728-734
19. Michalides RJ, Veelen NM van, Kristel PM, Hart AA, Loftus BM, Hilgers FJ, Balm AJ (1997) Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 123:497-502
20. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A (1991) A novel cyclin encoded by a bcl-1 linked candidate oncogene. Nature 350:512-515
21. Nakamura S, Yatabe Y, Seto M (1997) Cyclin D1 overexpression in malignant lymphomas. Pathol Int 47:421-429
22. Peters G (1994) The D-type cyclins and their role in tumorigenesis. J Cell Sci 8:89-96
23. Peters G, Fantl V, Smith R, Brookes S, Dickson C (1995) Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res Treat 33:125-135
24. Quelle DE, Ashmun RA, Shrtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ (1993) Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7:1559-1571
25. Sewing A, Burger S, Brusselbach S, Schalk C, Lucibello FC, Muller R (1993) Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J Cell Sci 104:545-554
26. Sherr CJ (1993) Mammalian G1 cyclins: Cell 73:1059-1065
27. Sherr CJ (1996) Cancer cell cycle. Science 274:1672-1677
28. Tam SW, Theodoras AM, Shay JW, Draetta GF, Pagano M (1994) Differential expression and regulation of cyclin D1 protein in normal and tumor cells: association with cdk4 is required for cyclin D1 function in G1 progression. Oncogene 9:2663-2674
29. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671
30. Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL, Steeg PS (1995) Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med 1:1257-1260
31. Worsley SD, Jennings BA, Khalil KH, Girling AC (1996) Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression. J Clin Pathol: Mol Pathol 49:M46-M50
32. Xiong Y, Connolly T, Futcher B, Beach D (1991) Human D-type cyclin. Cell 65:691-699
33. Zukerberg LR, Yang WI, Gadd M, et al (1995) Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 8:560-567
34. Zwijsen RML, Wientjens E, Klompmaker R, Sman J van der, Bernards R, Michalides RJAM (1997) CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405-415